Cellcolabs is a Karolinska Institute spin-off producing stem cells at scale using manufacturing automation to cut cell therapy production costs.
This profile is maintained by the Sesamers data desk. Claim it to edit details, post jobs and answer interviews.
€10,300,000
Total raised
-
Valuation
78
Employees
2021
Founded
Latest round
Equity - October 27, 2025
Equity - €10,300,000
October 27, 2025 · Read the story
✓ verified by our desk
Open roles
Cellcolabs is not hiring through Sesamers right now.
Work here? Claim the profile and post roles.
Claim your profile